| Mr John D Wenger, DO | |
|
1931 Medical Ave, Harrisonburg, VA 22801-3437 | |
| (540) 564-5400 | |
| (757) 579-8560 |
| Full Name | Mr John D Wenger |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 29 Years |
| Location | 1931 Medical Ave, Harrisonburg, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700815131 | NPI | - | NPPES |
| 1700815131 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 34.006884 (Ohio) | Secondary |
| 207Q00000X | Family Medicine | 0102202366 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sentara Rmh Medical Center | Harrisonburg, VA | Hospital |
| Vmrc, Complete Living Care | Harrisonburg, VA | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rmh Medical Group Llc | 7618270729 | 208 |
News Archive
With $3 billion spent on the over-treatment of prostate cancer each year, new discoveries are prompting the prostate cancer community to Advance on Washington the week of September 13 - 18. This initiative calls for renewed commitments to finding answers that will enable physicians to cure more and over-treat less. The nation's leading prostate cancer organizations today issued a five point plan, targeted to policymakers, to accelerate research and discovery of effective prostate cancer treatments.
Put patients first. That's what Mr Reid says. That's fine. Consultants do this every day. We don't need a politician to say it, like it's something we never thought of. When a consultant is working 50 hours a week despite only being paid for 35, that is putting the patient first. When a consultant is operating on an emergency patient in the middle of the night, that is putting the patient first.
GeoVax Labs, Inc., an Atlanta-based, biopharmaceutical company developing human vaccines for HIV/AIDS (HIV-1, Human Immunodeficiency Virus), was pleased to hear the announcement today of partial success in the recently completed Phase 3 trial in Thailand of a candidate HIV/AIDS vaccine owned by Sanofi-Aventis and Global Solutions for Infectious Diseases.
bioTheranostics, Inc., today introduced the bioT3 Metastatic Cancer Solution, a suite of genomic-based tests that provide personalized diagnostic information and therapeutic guidance for metastatic cancer patients across the continuum of care.
BioAlliance Pharma SA, a Company dedicated to orphan oncology products and specialty products, today announces the initiation of ReLive, its phase III clinical trial with Livatag(doxorubicin Transdrug), as scheduled in the advancement calendar of the project.
› Verified 7 days ago
| Entity Name | Rmh Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669844908 PECOS PAC ID: 7618270729 Enrollment ID: O20160125000666 |
News Archive
With $3 billion spent on the over-treatment of prostate cancer each year, new discoveries are prompting the prostate cancer community to Advance on Washington the week of September 13 - 18. This initiative calls for renewed commitments to finding answers that will enable physicians to cure more and over-treat less. The nation's leading prostate cancer organizations today issued a five point plan, targeted to policymakers, to accelerate research and discovery of effective prostate cancer treatments.
Put patients first. That's what Mr Reid says. That's fine. Consultants do this every day. We don't need a politician to say it, like it's something we never thought of. When a consultant is working 50 hours a week despite only being paid for 35, that is putting the patient first. When a consultant is operating on an emergency patient in the middle of the night, that is putting the patient first.
GeoVax Labs, Inc., an Atlanta-based, biopharmaceutical company developing human vaccines for HIV/AIDS (HIV-1, Human Immunodeficiency Virus), was pleased to hear the announcement today of partial success in the recently completed Phase 3 trial in Thailand of a candidate HIV/AIDS vaccine owned by Sanofi-Aventis and Global Solutions for Infectious Diseases.
bioTheranostics, Inc., today introduced the bioT3 Metastatic Cancer Solution, a suite of genomic-based tests that provide personalized diagnostic information and therapeutic guidance for metastatic cancer patients across the continuum of care.
BioAlliance Pharma SA, a Company dedicated to orphan oncology products and specialty products, today announces the initiation of ReLive, its phase III clinical trial with Livatag(doxorubicin Transdrug), as scheduled in the advancement calendar of the project.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr John D Wenger, DO Po Box 79777, Baltimore, MD 21279-0777 Ph: (540) 564-5400 | Mr John D Wenger, DO 1931 Medical Ave, Harrisonburg, VA 22801-3437 Ph: (540) 564-5400 |
News Archive
With $3 billion spent on the over-treatment of prostate cancer each year, new discoveries are prompting the prostate cancer community to Advance on Washington the week of September 13 - 18. This initiative calls for renewed commitments to finding answers that will enable physicians to cure more and over-treat less. The nation's leading prostate cancer organizations today issued a five point plan, targeted to policymakers, to accelerate research and discovery of effective prostate cancer treatments.
Put patients first. That's what Mr Reid says. That's fine. Consultants do this every day. We don't need a politician to say it, like it's something we never thought of. When a consultant is working 50 hours a week despite only being paid for 35, that is putting the patient first. When a consultant is operating on an emergency patient in the middle of the night, that is putting the patient first.
GeoVax Labs, Inc., an Atlanta-based, biopharmaceutical company developing human vaccines for HIV/AIDS (HIV-1, Human Immunodeficiency Virus), was pleased to hear the announcement today of partial success in the recently completed Phase 3 trial in Thailand of a candidate HIV/AIDS vaccine owned by Sanofi-Aventis and Global Solutions for Infectious Diseases.
bioTheranostics, Inc., today introduced the bioT3 Metastatic Cancer Solution, a suite of genomic-based tests that provide personalized diagnostic information and therapeutic guidance for metastatic cancer patients across the continuum of care.
BioAlliance Pharma SA, a Company dedicated to orphan oncology products and specialty products, today announces the initiation of ReLive, its phase III clinical trial with Livatag(doxorubicin Transdrug), as scheduled in the advancement calendar of the project.
› Verified 7 days ago
Wayne F Mcnett, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1661 S Main St, Harrisonburg, VA 22801 Phone: 540-564-7300 Fax: 757-431-7100 | |
John A Witman, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1751 Erickson Ave, Harrisonburg, VA 22801 Phone: 540-433-3344 Fax: 540-433-0031 | |
Gilbert C Rice Iii, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1790 E Market St Ste 64b, Harrisonburg, VA 22801 Phone: 540-564-5666 Fax: 757-579-8594 | |
Dr. James D Evans, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3322 Emmaus Rd, Harrisonburg, VA 22801 Phone: 540-433-2431 Fax: 540-433-9825 | |
Rebecca Botticelli, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1992 Medical Ave, Harrisonburg, VA 22801 Phone: 540-437-1296 Fax: 540-437-1298 | |
Jeffrey A Ashby, M.D. Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 1831 Reservoir St, Harrisonburg, VA 22801 Phone: 540-433-9151 Fax: 540-433-0547 | |
Dr. Gregory C Jesteadt Ix, M.D. Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 1831 Reservoir St, Harrisonburg, VA 22801 Phone: 540-433-9151 |